179 related articles for article (PubMed ID: 34958836)
1. Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis.
Garrido A; Kim E; Teijeiro A; Sánchez Sánchez P; Gallo R; Nair A; Matamala Montoya M; Perna C; Vicent GP; Muñoz J; Campos-Olivas R; Melms JC; Izar B; Schwabe RF; Djouder N
J Hepatol; 2022 Apr; 76(4):850-861. PubMed ID: 34958836
[TBL] [Abstract][Full Text] [Related]
2. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
3. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.
Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447
[TBL] [Abstract][Full Text] [Related]
4. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
Fickert P; Fuchsbichler A; Moustafa T; Wagner M; Zollner G; Halilbasic E; Stöger U; Arrese M; Pizarro M; Solís N; Carrasco G; Caligiuri A; Sombetzki M; Reisinger E; Tsybrovskyy O; Zatloukal K; Denk H; Jaeschke H; Pinzani M; Trauner M
Am J Pathol; 2009 Dec; 175(6):2392-405. PubMed ID: 19910507
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
[TBL] [Abstract][Full Text] [Related]
7. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
8. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor.
Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q
Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568
[TBL] [Abstract][Full Text] [Related]
10. Sodium
Salhab A; Amer J; Lu Y; Safadi R
Gut; 2022 Jul; 71(7):1373-1385. PubMed ID: 34266968
[TBL] [Abstract][Full Text] [Related]
11. n-3 Fatty Acids Abrogate Dyslipidemia-Induced Changes in Bile Acid Uptake, Synthesis, and Transport in Young and Aged Dyslipidemic Rats.
Acharya P; Talahalli RR
Lipids; 2019 Jan; 54(1):39-51. PubMed ID: 30740707
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.
Fu ZD; Cui JY; Klaassen CD
J Lipid Res; 2014 Dec; 55(12):2576-86. PubMed ID: 25278499
[TBL] [Abstract][Full Text] [Related]
13. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
[TBL] [Abstract][Full Text] [Related]
14. Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.
Feng S; Xie X; Li J; Xu X; Chen C; Zou G; Lin G; Huang T; Hu R; Ran T; Han L; Zhang Q; Li Y; Zhao X
Hepatol Int; 2024 Jun; 18(3):1040-1052. PubMed ID: 38172440
[TBL] [Abstract][Full Text] [Related]
15. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
17. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.
Aguilar-Olivos NE; Carrillo-Córdova D; Oria-Hernández J; Sánchez-Valle V; Ponciano-Rodríguez G; Ramírez-Jaramillo M; Chablé-Montero F; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
Ann Hepatol; 2015; 14(4):487-93. PubMed ID: 26019035
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.
Li J; Song J; Yan B; Weiss HL; Weiss LT; Gao T; Evers BM
FASEB J; 2021 May; 35(5):e21371. PubMed ID: 33811694
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
